The feasibility of using short-term cultures of ovarian cancer cells for use as autologous tumor cell vaccines as adjuvant treatment of advanced ovarian cancer

Cancer Biotherapy and Radiopharmaceuticals

Volumn 14, Issue 6, 1999, Pages 443-449

  Dillman, Robert O ^a   Nayak, Shankar K ^a   Brown, John V ^a   Mahdavi, Khosrow ^a   Beutel, Linda D ^a  

^a HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

Author keywords

Cell cultures; Cell lines; Ovarian cancer; Vaccines

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR VACCINE;

ADVANCED CANCER; AGED; ARTICLE; AUTOGRAFT; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; DELAYED HYPERSENSITIVITY; DRUG EFFECT; FEMALE; HUMAN; IMMUNOTHERAPY; OVARY CANCER; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0033402468     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1999.14.443     Document Type: Article

References (20)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. Cancer CA J Clin 1998;48:6-30.
2. Cannistra SA. Cancer of the ovary. N Engl J Med 1993;329:1550-1559.
3. NIH Consensus Development Panel on Ovarian Cancer. Ovarian cancer. JAMA 1995;273:491-497.
4. Boente MP, Chi DS, Hoskins WJ. The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery. Semin Oncol 1998; 25:326-334.
5. McGuire WP, Ozols RF. Chemotherapy of advanced ovarian cancer. Semin Oncol 1998;25:340-348.
6. Granai CO. Ovarian cancer - unrealistic expectations. N Engl J Med 1992;327:197-200.
7. Bookman MA. Biological therapy of ovarian cancer: current directions. Semin Oncol 1998;25:381-396.
8. Gurski KJ, Steller MA. Progress and prospects in vaccine therapy for gynecologic cancers. Oncology 1997;11:1727-1740.
9. Dillman RO, Nayak SK, Beutel L. Establishing in vitro cultures of autologous tumor cells for use in active specific immunotherapy. J Immunother 1993;14:65-69.
10. Nayak SK, McCallister T, Han LJ, Gangavalli R, Barber J, Dillman RO. Transduction of human renal carcinoma cells with human γ-interferon gene via retroviral vector. Cancer Gene Ther 1996;3:143-150.
11. Dillman RO, Nayak SK, Barth NM, DeLeon C, Schwartzberg LS, O'Connor AA, Spitler LE, Beutel LD. Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma. Cancer Biother 1998;13: 165-176.
12. Nayak SK, Dillman RO. Establishment of multiple tumor cell lines from a patient with melanoma: a simple method to control fibroblast growth. Clin Biotechnol 1991;3:237-242.
13. th ed. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ eds. Philadelphia, JB Lippincott Company, 1992.
14. Hirte HW, Kaiser JS, Bacchetti S. Establishment and characterization of four human epithelial ovarian carcinoma cell lines. Cancer 1994;74:900-906.
15. Golombick T, Dansey R, Bezwoda WR, Rosendorff J. Establishment and characterization of two new human ovarian cancer cell lines UWOV1 and UWOV2 and a subline UWOV2(SF) growing in serum-free conditions: growth characteristics, biochemical, and cytogenetic studies. In Vitro Cell Dev Biol 1990; 26:447-454.
16. Mobus V, Gerharz CD, Press U, Moll R, Beck T, Mellin W, Pollow WK, Knapstein K, Kreienberg R. Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines. Int J Cancer 1992;52:76-84.
17. Ramakrishna V, Negri DR, Brusic V, Fontanelli R, Canevari S, Bolis G, Castelli C, Parmiani G. Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted by cytotoxic T-cells. Int J Cancer 1997;73:143-50.
18. Stiff PJ, Bayer R, Kerger C, Potkul RK, Malhotra D, Peace DJ, Smith D, Fisher SG. High-dose chemotherapy with autologous transplantation for persistent/ relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. J Clin Oncol 1997;15:1309-1317.
19. Legros M, Dauplat J, Fleury J, Cure H, Suzanne F, Chassagne J, Bay JO, Col C, Canis M, Condat P, Choufi B, Tavemier F, Glenat C, Chollet P, Plagne R. Hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results. J Clin Oncol 1997; 15:1302-1308.
20. Markman M. Intraperitoneal therapy of ovarian cancer. Semin Oncol 1998;25:356-36